Compositions for inhibiting platelet aggregation

Details Compositions for inhibiting platelet aggregation Compositions for inhibiting platelet aggregation

A - Human Necessities

61

K

A61K 31/445 (2006.01)

Patent

CA 2234364

The invention is a pharmaceutical composition for intravenous administration to a patient comprising a) a pharmaceutically effective amount of a compound having formula (I), for example 2-S-(n-Butylsulfonylamino)-3-[4-(4-(piperidin- 4-yl)butyloxy)phenyl]propionic acid; b) a pharmaceutically acceptable amount of a citrate buffer effective to provide a pH of between about 5 and 7; and c) a pharmaceutically acceptable amount of a tonicity adjusting agent effective to make the formulation substantially isotonic with the osmotic pressure of the biological system of the patient.

L'invention concerne une composition pharmaceutique à administrer par voie intraveineuse à un patient, comprenant: a) une dose pharmaceutiquement efficace d'un composé de formule (I), par exemple de l'acide 2-S-(n-butylsulfonylamino)-3-[4-(4-(pipéridine-4-yl)butyloxy)phényl]propionique; b) une dose pharmaceutiquement acceptable d'un tampon de citrate garantissant un pH compris entre environ 5 et 7; et c) une dose pharmaceutiquement acceptable d'un agent ajustant la tonicité, rendant la formulation sensiblement isotonique par rapport à la pression osmotique du système biologique du patient concerné.

Affiliated with

Also associated with

Rating

Compositions for inhibiting platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions for inhibiting platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for inhibiting platelet aggregation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1697776